Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer
Status:
Unknown status
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The primary objectives of this control, single-center clinical study of EndostarTM Injection
with/without SOX protocols to treat advanced gastric cancer were to evaluate the clinical
response rate of Endostar injection concomitant with SOX on patients with advanced gastric
cancer, observe the progression-free survival time (PFS) of tumor and evaluate the safety and
tolerance of Endostar injection, while the secondary objectives were to observe the influence
of Endostar injection on chemotherapy-induced adverse reactions and evaluate the overall
survival time of EndostarTM injection concomitant with SOX on patients with advanced gastric
cancer by evaluating the response rate (RR) clinical benefit rate (CBR), progression-free
survival (PFS) and overall survival (OS).